Your activity: 46 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Castor oil: Pediatric drug information

Castor oil: Pediatric drug information
(For additional information see "Castor oil: Drug information")

For abbreviations, symbols, and age group definitions used in Lexicomp (show table)
Brand Names: US
  • GoodSense Castor Oil [OTC]
Therapeutic Category
  • Laxative, Stimulant
Dosing: Pediatric

Note: Produces bowel evacuation in 6 to 12 hours. Use of castor oil has generally been replaced with other laxatives (eg, PEG solutions, lactulose) less likely to cause adverse effects (eg, electrolyte disturbances) (Tabbers 2014):

Constipation, occasional

Constipation, occasional: Oral:

Children 2 to 11 years: 5 to 15 mL as a single daily dose as needed

Children ≥12 years and Adolescents: 15 to 60 mL as a single daily dose as needed

Dosing: Kidney Impairment: Pediatric

There are no dosage adjustments provided in the manufacturer’s labeling.

Dosing: Hepatic Impairment: Pediatric

There are no dosage adjustments provided in the manufacturer’s labeling.

Dosing: Adult

(For additional information see "Castor oil: Drug information")

Bowel evacuation, constipation

Bowel evacuation, constipation: Oil: Oral: 15 to 60 mL as a single dose.

Dosage Forms: US

Excipient information presented when available (limited, particularly for generics); consult specific product labeling.

Oil, Oral:

GoodSense: (118 mL)

Generic: (59 mL, 118 mL, 177 mL, 473 mL)

Generic Equivalent Available: US

No

Administration: Pediatric

Oral: Do not administer at bedtime because of rapid onset of action; chill or administer with milk, juice, or carbonated beverage to improve palatability; administer on an empty stomach for quicker onset (Brunton 2006)

Administration: Adult

Do not administer at bedtime because of rapid onset of action. Should be administered on an empty stomach with juice or carbonated beverages.

Storage/Stability

Protect from heat.

Use

Treatment of occasional constipation (OTC product: FDA approved in ≥2 years and adults)

Adverse Reactions

There are no adverse reactions listed in the manufacturer's labeling.

Warnings/Precautions

Other warnings/precautions:

• Appropriate use: Do not use for longer than 1 week or when abdominal pain, nausea, vomiting, or rectal bleeding are present unless directed by health care provider.

Metabolism/Transport Effects

None known.

Drug Interactions

Note: Interacting drugs may not be individually listed below if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed). For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.

Note: Interacting drugs may not be individually listed below if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed). For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program

Sodium Sulfate: Laxatives (Stimulant) may enhance the adverse/toxic effect of Sodium Sulfate. Specifically, the risk of mucosal ulceration or ischemic colitis may be increased. Risk X: Avoid combination

Dietary Considerations

Should be taken on an empty stomach with juice or carbonated beverages.

Pregnancy Considerations

Ingestion of castor oil may be associated with induction of labor. Use of castor oil as a laxative during pregnancy should be avoided (Cullen 2007; Hall 2011; Wald 2003).

Monitoring Parameters

Stool output, electrolytes

Mechanism of Action

Acts primarily in the small intestine; hydrolyzed to ricinoleic acid which reduces net absorption of fluid and electrolytes and stimulates peristalsis

Pharmacokinetics (Adult data unless noted)

Onset of action: 1 to 3 hours (Brunton 2006) but may take up to 12 hours

Pricing: US

Oil (Castor Oil Oral)

100% (per mL): $0.02

Disclaimer: A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer. Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions. In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data. Pricing data is updated monthly.

Brand Names: International
  • Laxatrol (PH);
  • Laxol (BR);
  • Oleum Ricini (BG, EE);
  • Ricilaks (TR);
  • Riciment (TR);
  • Ricipan (TR)


For country code abbreviations (show table)
  1. Brunton LL, Chabner BA, Knollmann BC, eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill Medical; 2006.
  2. Cullen G, O'Donoghue D. Constipation and pregnancy. Best Pract Res Clin Gastroenterol. 2007;21(5):807-818. [PubMed 17889809]
  3. GoodSense Castor Oil [prescribing information]. St. Louis, MO: Vi-Jon Inc; May 2020.
  4. Hall HG, McKenna LG, Griffiths DL. Complementary and alternative medicine for induction of labour. Women Birth. 2012;25(3):142-148. [PubMed 21524953]
  5. Humco Castor Oil liquid [prescribing information]. Texarkana, TX; Humco; October 2013.
  6. Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58(2):258-274. [PubMed 24345831]
  7. Wald A. Constipation, diarrhea, and symptomatic hemorrhoids during pregnancy. Gastroenterol Clin North Am. 2003;32(1):309-322. [PubMed 12635420]
Topic 13121 Version 91.0